Evidence map›Paper›PMID 40526130›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2026

Optimizing energy consumption in radiotherapy: standard vs. hypo-/ultra-hypofractionation and becoming SMART (specific, measurable, achievable in radiotherapy).

Ann-Katrin Exeli, Andreas Lurtz, Linda Agolli, Daniel Habermehl

Abstract readComparative Study
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. SUSTAIN-RO study: a nationwide pilot survey on environmental sustainability practices among Spanish radiation oncology specialists.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Sustainability in German radiotherapy: professionals' perspectives on energy savings-results of a DEGRO working group survey.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ann-Katrin ExeliDepartment of Radiotherapy, Giessen, University Hospital Giessen-Marburg, Klinikstr. 33, 35392, Giessen, Germany. ann-katrin.exeli@uk-gm.de.
Andreas LurtzDepartment of Radiotherapy, Giessen, University Hospital Giessen-Marburg, Klinikstr. 33, 35392, Giessen, Germany.
Linda AgolliDepartment of Radiotherapy, Giessen, University Hospital Giessen-Marburg, Klinikstr. 33, 35392, Giessen, Germany.
Daniel HabermehlDepartment of Radiotherapy, Giessen, University Hospital Giessen-Marburg, Klinikstr. 33, 35392, Giessen, Germany.ORCID 0009-0007-7316-6422

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe healthcare sector is a large greenhouse gas producer. Especially in radiotherapy (RT), a lot of electricity is consumed by the medical linear accelerator (linac) and associated patient travel. Our aim was to ascertain by how much electrical energy consumption and patient travel can be reduced by replacing normofractionated (NF) with emerging moderately hypofractionated (UF) or ultra-hypofractionated (UHF) concepts.

methodsWe connected an energy meter to our linac (VersaHD, Elekta©, Stockholm, Sweden) and evaluated different fractionation concepts (NF, HF, UHF) for 30 patients with target volumes of the prostate, breast, and spine. In addition to the energy measurements, we also conducted an analysis of the carbon dioxide (CO

resultsThis study measured the energy consumption of a linac (in kWh) and its impact on CO

conclusionThe adoption of HF and UHF treatment concepts can significantly reduce energy consumption and CO

Indexed as

NeoplasmsParticle AcceleratorsRadiation Dose HypofractionationBreast NeoplasmsCarbon DioxideDose Fractionation, RadiationFemaleHumansMaleProstatic NeoplasmsCarbon DioxideCarbon footprintHypofractionationRadiotherapySustainabilityUltra-hypofractionation

Identifiers

PMID40526130
PMCPMC12872622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.